Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18076 - 18100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	CYLD	1540	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYLD mRNA	16q12.1	A21749
Copper	Approved Investigational	CYP1B1	1545	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYP1B1 mRNA	2p22.2	A21749
Copper	Approved Investigational	CYP27B1	1594	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYP27B1 mRNA	12q14.1	A21749
Copper	Approved Investigational	CYP2R1	120227	upregulated	[Disulfiram binds to Copper] which results in increased expression of CYP2R1 mRNA	11p15.2	A21750
Copper	Approved Investigational	CYP4F11	57834	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYP4F11 mRNA	19p13.12	A21749
Copper	Approved Investigational	CYR61	3491	upregulated	Copper results in increased expression of CYR61 mRNA	1p22.3	A21752
Copper	Approved Investigational	CYR61	3491	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYR61 mRNA	1p22.3	A21749
Copper	Approved Investigational	CYSTM1	84418	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CYSTM1 mRNA	5q31.3	A21749
Copper	Approved Investigational	DACH1	1602	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of DACH1 mRNA	13q21.33	A21749
Copper	Approved Investigational	DAG1	1605	upregulated	[Disulfiram binds to Copper] which results in increased expression of DAG1 mRNA	3p21.31	A21750
Copper	Approved Investigational	DAW1	164781	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DAW1 mRNA	2q36.3	A21749
Copper	Approved Investigational	DBI	1622	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of DBI mRNA	2q14.2	A21749
Copper	Approved Investigational	DCAF13	25879	downregulated	[Disulfiram binds to Copper] which results in decreased expression of DCAF13 mRNA	8q22.3	A21750
Copper	Approved Investigational	DCAF13	25879	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DCAF13 mRNA	8q22.3	A21749
Copper	Approved Investigational	DCTPP1	79077	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of DCTPP1 mRNA	16p11.2	A21749
Copper	Approved Investigational	DDC	1644	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DDC mRNA	7p12.2-p12.1	A21749
Copper	Approved Investigational	DDIT3	1649	downregulated	[Disulfiram binds to Copper] which results in decreased expression of DDIT3 mRNA	12q13.3	A21750
Copper	Approved Investigational	DDIT3	1649	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DDIT3 mRNA	12q13.3	A21749
Copper	Approved Investigational	DDIT4	54541	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DDIT4 mRNA	10q22.1	A21749
Copper	Approved Investigational	DDX10	1662	upregulated	[NSC 689534 binds to Copper] which results in increased expression of DDX10 mRNA	11q22.3	A21749
Copper	Approved Investigational	DDX46	9879	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of DDX46 mRNA	5q31.1	A21749
Copper	Approved Investigational	DDX60	55601	upregulated	[Disulfiram binds to Copper] which results in increased expression of DDX60 mRNA	4q32.3	A21750
Copper	Approved Investigational	DEAF1	10522	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of DEAF1 mRNA	11p15.5	A21749
Copper	Approved Investigational	DEDD2	162989	downregulated	[Disulfiram binds to Copper] which results in decreased expression of DEDD2 mRNA	19q13.2	A21750
Copper	Approved Investigational	DEFB103B	55894	downregulated	[Disulfiram binds to Copper] which results in decreased expression of DEFB103B mRNA	8p23.1	A21750

Displaying entries 18076 - 18100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability